Back to search

Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy

Data up to Jan 2025

Published2001
Citations335
References24
Clinical Trials (1)

Total Citations Per Year

Abstract

References (24)

Phenotypic Analysis of Antigen-Specific T Lymphocytes

1996 • 3,611 citations

Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function

1998 • 1,890 citations

Changes in thymic function with age and during the treatment of HIV infection

1998 • 1,887 citations

Hepatitis B Virus Immunopathogenesis

1995 • 1,568 citations

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1998 • 1,426 citations

Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus

2000 • 1,270 citations

Intracellular Inactivation of the Hepatitis B Virus by Cytotoxic T Lymphocytes

1996 • 1,085 citations

The Role of Virus-Specific Cd8+ Cells in Liver Damage and Viral Control during Persistent Hepatitis B Virus Infection

2000 • 792 citations

The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis.

1995 • 483 citations

Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.

1998 • 459 citations

Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen.

1991 • 363 citations

Direct ex vivo analysis of hepatitis B virus-specific CD8+ T cells associated with the control of infection

1999 • 358 citations

Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy

1999 • 350 citations

Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy

2001 • 335 citations

HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.

1993 • 333 citations

Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection.

1996 • 299 citations

Frequency of Class I HLA-Restricted Anti-HIV CD8+ T Cells in Individuals Receiving Highly Active Antiretroviral Therapy (HAART)

1999 • 274 citations

The Secreted Hepatitis B Precore Antigen Can Modulate the Immune Response to the Nucleocapsid: A Mechanism for Persistence

1998 • 215 citations

Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver.

1996 • 199 citations

Role of Lymphoid Organs in the Pathogenesis of Human Immunodeficiency Virus (HIV) Infection

1994 • 188 citations

Hepatitis B Virus Immunopathogenesis

1995 • 116 citations

In vitroimmunotoxicity of ±2′-deoxy-3′-thiacytidine, a new and-HIV agent

1993 • 16 citations

[Immune response to viral infection].

1992 • 15 citations

In vitro Toxicity of 2′,3′-Dideoxy-3′-Thiacytidine (BCH189/3TC), a New Synthetic Anti-HIV-1 Nucleoside

1992 • 6 citations

Cited By (0)

Loading...
Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic… (2001) – Hepatology | Metascience Observatory Explorer